Christopher R. Cline, CFO: Travere Therapeutics TVTX Planned sale · Filed 09/15

Trade details

Type: Planned sale notice
Stock: Travere Therapeutics TVTX
Person: Christopher R. ClineCFO
Planned sale date: 26/09/15
Filed: 26/09/15

More to sell after $42.6K in 3 months

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 08/16~10/15

Christopher R. Cline's recent trades

Christopher R. ClineCFO
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$101.7K
2,181 sh
$101.7K
Filed 05/06
Traded 05/05
Christopher R. ClineCFO
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$13.6K
310 sh
$13.6K
Filed 05/06
Traded 05/06
Christopher R. ClineCFO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$13.6K
310 sh
$13.6K
Filed 05/06
Traded 05/06
Christopher R. ClineCFO
Planned saleTravere Therapeutics
Planned sale
Travere Therapeutics
TVTX
$101.7K
2,181 sh
$101.7K
Filed 05/05
Traded 05/05
Christopher R. ClineCFO
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$303.5K
7,239 sh
$303.5K
Filed 04/15
Traded 04/14

Christopher R. Cline, CFO — plans to sell 50,508 sh of Travere Therapeutics TVTX · $3.3M · around 09/15 · 10b5-1 plan | Whalegun